Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?
Bulbus fritillariae cirrhosae (BFC) is one of the most used Chinese medicines for lung disease, and exerts antitussive, expectorant, anti-inflammatory, anti-asthmatic, and antioxidant effects, which is an ideal therapeutic drug for respiratory diseases such as ARDS, COPD, asthma, lung cancer, and pu...
Saved in:
Main Authors: | Yunyun Quan (Author), Li Li (Author), Zhujun Yin (Author), Shilong Chen (Author), Jing Yi (Author), Jirui Lang (Author), Lu Zhang (Author), Qianhua Yue (Author), Junning Zhao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular quantification of fritillariae cirrhosae bulbus and its adulterants
by: Ziyi Liu, et al.
Published: (2024) -
Determination of ITS1 haplotypes of Fritillariae Cirrhosae Bulbus by amplicon sequencing
by: Hoi-Yan Wu, et al.
Published: (2024) -
Natural Fostering in Fritillaria cirrhosa: Integrating herbal medicine production with biodiversity conservation
by: Xiwen Li, et al.
Published: (2012) -
LC-MS-based metabolomics reveals the mechanism of anti-gouty arthritis effect of Wuwei Shexiang pill
by: Jirui Lang, et al.
Published: (2023) -
The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin
by: Yunyun Quan, et al.
Published: (2022)